News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,204 Results
Type
Article (2582)
Company Profile (45)
Press Release (37576)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14229)
Career Advice (78)
Deals (2115)
Drug Delivery (9)
Drug Development (4150)
Employer Resources (10)
FDA (443)
Job Trends (792)
News (20320)
Policy (1059)
Tag
Academia (145)
Allergies (7)
Alliances (3508)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (446)
Artificial intelligence (32)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (486)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (325)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (3)
Clinical research (3441)
Collaboration (200)
Company closure (2)
Compensation (104)
COVID-19 (186)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (422)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (492)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4521)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6409)
Executive appointments (135)
FDA (588)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (63)
Government (158)
Guidances (24)
Healthcare (711)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (198)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1004)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (4)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (314)
Medtech (315)
Mergers & acquisitions (1228)
Metabolic disorders (72)
Multiple sclerosis (23)
Neurodegenerative disease (28)
Neuropsychiatric disorders (10)
Neuroscience (165)
NextGen: Class of 2026 (353)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5881)
Pharmaceutical (5)
Phase 1 (1477)
Phase 2 (1704)
Phase 3 (917)
Pipeline (393)
Policy (16)
Postmarket research (30)
Preclinical (641)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (426)
Recruiting (5)
Regulatory (918)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (53)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (39)
Last 30 days (162)
Last 365 days (2424)
2026 (211)
2025 (2455)
2024 (2630)
2023 (2888)
2022 (3772)
2021 (4054)
2020 (3476)
2019 (2062)
2018 (1554)
2017 (1796)
2016 (1625)
2015 (1833)
2014 (1370)
2013 (1192)
2012 (1399)
2011 (1333)
2010 (1182)
Location
Africa (44)
Alabama (4)
Arizona (18)
Asia (1952)
Australia (308)
California (1606)
Canada (242)
China (80)
Colorado (54)
Connecticut (18)
Delaware (5)
Europe (4066)
Florida (64)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (576)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (80)
North Carolina (132)
Northern California (783)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (655)
Tennessee (4)
Texas (152)
United States (3219)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,204 Results for "olink bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel
September 16, 2025
·
4 min read
Press Releases
Regeneron Genetics Center Selects Olink® Explore HT for Landmark Proteomics Study of 200,000 Patient Samples
June 12, 2025
·
3 min read
Business
Olink publishes 2023 annual report
Olink Holding AB announced that the Annual Report for 2023 is now available on the Company’s website.
March 25, 2024
·
1 min read
Business
Olink reports first quarter 2024 financial results
Olink Holding AB announced its unaudited financial results for the first quarter ended March 31, 2024.
May 13, 2024
·
15 min read
Olink announces change of date for Annual General Meeting - March 08, 2024
Olink Holding AB, announced that Olink’s 2024 Annual General Meeting will be held in Uppsala, Sweden on April 19th, 2024.
March 8, 2024
·
1 min read
Press Releases
Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization
June 19, 2025
·
2 min read
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
Olink Holding AB announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a detailed view of the immune system for in-depth monitoring of inflammation and immune response in clinical research.
June 6, 2024
·
5 min read
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
Olink Holding AB reported the publication of a landmark study using the Olink Explore platform to identify proteins in the blood that may provide a 7-year warning for various cancers.
May 30, 2024
·
5 min read
Business
Olink reports fourth quarter and full year 2023 financial results
Olink Holding AB announced its unaudited financial results for the fourth quarter ended December 31, 2023.
March 25, 2024
·
17 min read
Business
Olink reports third quarter 2023 financial results
Olink Holding AB announced its unaudited financial results for the third quarter ended September 30, 2023.
November 15, 2023
·
15 min read
1 of 4,021
Next
